rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Roper Technologies, Inc.

ROP · Nasdaq

Health CareLife-science toolsJust started moving

ROP stood above a rising 150-day average in 7 of the last 52 weekly readings, including each of the last 7 weeks. It is 20.1% above that average now. Life Science Tools & Research Services: 48% of its 79 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−6 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
7 in a row
Industry in uptrend
48% -5 in 4 wk
Insider buys, 12 months
$6.1M
Insider sales, 12 months
$22.1M
Officials’ trades on record
91
Institutions holding
1,008 (-64)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 7 of 52 weeks.

23 Apr – 22 Oct
28%42%57%Apr 26Jun 26Jul 26Sep 26Oct 26

Life-science tools: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$16.7M$0$4.2MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

91 disclosed lines: House 65, Senate 4, executive 22; 19 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k8 Jul 2026filed 22 Sep 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$50k–$100k24 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$500k–$1M18 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k16 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k12 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$1k–$15k3 Jun 2026filed 22 Aug 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$50k–$100k22 May 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31sold$1k–$15k15 May 2026filed 8 Jun 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$15k–$50k11 May 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$250k–$500k17 Apr 2026filed 1 Jul 2026
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officebought$15k–$50k15 Apr 2026filed 1 Jul 2026
Gilbert Ray Cisneros, Jr. House: U.S. House ClerkCA31bought$1k–$15k14 Apr 2026filed 8 May 2026

Insiders

Buy orders, 12 months3
Sale orders, 12 months4
Buyers · sellers3 · 4
WhoDidSharesTraded
John K. StipancichEVP, Chief Legal Officer & Secsold2,000at $379.0527 Jul 2026filed 27 Jul 2026
Richard F. WallmanDirectorsold6,434at $361.0024 Jul 2026filed 27 Jul 2026
Thomas Patrick Joyce, Jr.Directorbought1,400at $358.466 Feb 2026filed 6 Feb 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders1,008-64 on the quarter
New · exited97 · 162
Reported value$33.8B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20269,890,694$3.3B+410,729+4.3%
WINDACRE PARTNERSHIP LLCadded · filed 14 Aug 20268,630,200$2.9B+1,132,200+15.1%
Dodge & Coxadded · filed 13 Aug 20267,060,583$2.4B+3,716,889+111.2%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20266,593,203$2.2B-214,929−3.2%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20265,741,899$1.9B-66,619−1.1%
STATE STREET CORPadded · filed 7 Aug 20265,158,880$1.7B+21,032+0.4%
Invesco Ltd.added · filed 14 Aug 20264,270,321$1.4B+2,076,076+94.6%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20263,118,342$1.1B+316,926+11.3%
WELLINGTON MANAGEMENT GROUP LLPreduced · filed 14 Aug 20262,631,070$890.3M-35,999−1.3%
NORGES BANKnew · filed 12 Aug 20262,074,272$701.9M+2,074,272
31 Mar 2023 – 30 Jun 2026
91710751232Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Abhijit Dubey Company insiderDirector · last 1 Oct 20260 · 0
Irene M. Esteves Company insiderDirector · last 15 Sep 20260 · 0
Shellye L. Archambeau Company insiderDirector · last 15 Sep 20260 · 1
Thomas Patrick Joyce Jr. Company insiderDirector · last 15 Sep 20261 · 0
John K. Stipancich Company insiderEVP, Chief Legal Officer & Sec · last 27 Jul 20260 · 9
Richard F. Wallman Company insiderDirector · last 24 Jul 20268 · 9
Donald J. Trump Executive branchWhite House Office · last 8 Jul 202613 · 9
Amy Woods Brinkley Company insiderDirector · last 20 May 20261 · 3
John Francis Murphy Company insiderDirector · last 20 May 20260 · 0
Laura G. Thatcher Company insiderDirector · last 20 May 20260 · 1
Robert D. Johnson Company insiderDirector · last 20 May 20260 · 49
Gilbert Ray Cisneros, Jr. HouseCA31 · last 15 May 20262 · 3

Same industry

OABI OmniAbLeading+67%
TXG 10x GenomicsLeading+55%
AVTR AvantorLeading+51%
ILMN IlluminaLeading+45%
RVTY RevvityLeading+39%
SDGR SchrodingerLeading+30%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 31 Dec 202569.2%
Operating profit marginFY 2025 · to 31 Dec 202528.3%
Return on capital employedFY 2025 · to 31 Dec 20257.2%
Cash conversionFY 2025 · to 31 Dec 2025165%
Debt to equityFY 2025 · to 31 Dec 20250.50×
Research spendFY 2025 · to 31 Dec 202510.8%
Share count trendFY 2025 · to 20 Feb 2026-3.4%
Cash and equivalentsFY 2025 · to 31 Dec 2025$297.4M

Analyst forecasts

No analyst forecasts yet.